Risk of peritoneal dissemination in stomach cancer Cover

.blurhash-client-img { display: none !important; }

Risk of peritoneal dissemination in stomach cancer

Current Issues in Pharmacy and Medical Sciences

Volume 30 (2017): Issue 4 (December 2017)

By: Robert Sitarz, Wojciech P Polkowski, Ryszard Maciejewski and G Johan A Offerhaus

Open Access

|Mar 2018

Authors

Robert Sitarz

r.sitarz@umlub.pl

Department of Pathology, University Medical Center Utrecht, Netherlands

Department of Anatomy, Medical University of Lublin, Lublin, Poland

Wojciech P Polkowski

Department of Surgical Oncology, Medical University of Lublin, Poland

Ryszard Maciejewski

Department of Anatomy, Medical University of Lublin, Lublin, Poland

G Johan A Offerhaus

Department of Pathology, University Medical Center Utrecht, Netherlands

DOI: https://doi.org/10.1515/cipms-2017-0034 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X

Journal RSS Feed

Language: English

Page range: 184 - 186

Submitted on: Sep 27, 2017

|

Accepted on: Dec 29, 2017

|

Published on: Mar 9, 2018

Published by: Sciendo

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

gastric cancer,

peritoneal dissemination,

immunohistochemistry

Related subjects:

Clinical medicine,

Clinical medicine, other,

Pharmacology, toxicology,

Pharmacy, other

© 2018 Robert Sitarz, Wojciech P Polkowski, Ryszard Maciejewski, G Johan A Offerhaus, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 30 (2017): Issue 4 (December 2017)Next article